Tg(CAG-Z-miR-21-EGFP) [31 (link)] mice (backcrossed on a C57BL6/J background for >10 generations) were crossed with Ins1tm1(CreERT2)Thor [32 (link)] mice to generate Tg(βmiR-21) mice. Eight-week Tg(βmiR-21) mice and littermate controls (Cre+ and Cre-) were treated with 1 mg/day x 6 days intraperitoneal (IP) tamoxifen. IP glucose tolerance tests (IPGTTs) were performed 21-days post tamoxifen injection after overnight fast, using 2 g/kg body weight of glucose [28 (link)]. Tail vein glucose was determined (AlphaTRAK glucometer; Abbott) at 0, 10, 20, 30, 60, 90, and 120-min post injection. Insulin sensitivity was measured with IP insulin tolerance testing (IPITT) after a 2-h fast, using IP injection of 0.75 U/kg bodyweight of regular humulin-R insulin (Eli Lilly) [28 (link)]. Tail vein glucose was measured at 0, 10, 20, 30, and 60min post injection. Islets were isolated using collagenase 28 days after the initial tamoxifen injection [33 (link)].
Free full text: Click here